Mukul Mishra

Sector-10, Jankipuram Extension, Sitapur Road
Lucknow, UP 226031, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Correction: FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1.

Correction: FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1.

Journal: Molecular cancer research : MCR

Published: August 04, 2026

Nemo-like kinase blocks myeloid differentiation by targeting tumor suppressor C/EBPα in AML.

Nemo-like kinase blocks myeloid differentiation by targeting tumor suppressor C/EBPα in AML.

Journal: The FEBS journal

Published: January 24, 2024

Ormeloxifene, a nonsteroidal antifertility drug promotes megakaryocyte differentiation in leukemia cell line K562.

Ormeloxifene, a nonsteroidal antifertility drug promotes megakaryocyte differentiation in leukemia cell line K562.

Journal: Cell biology international

Published: July 05, 2022

SOX4-mediated FBW7 transcriptional upregulation confers Tamoxifen resistance in ER+ breast cancers via GATA3 downregulation.

SOX4-mediated FBW7 transcriptional upregulation confers Tamoxifen resistance in ER+ breast cancers via GATA3 downregulation.

Journal: Life sciences

Published: March 13, 2022

CDK2-instigates C/EBPα degradation through SKP2 in Acute myeloid leukemia.

CDK2-instigates C/EBPα degradation through SKP2 in Acute myeloid leukemia.

Journal: Medical oncology (Northwood, London, England)

Published: March 20, 2021

Proteomic analysis of TGFβ-induced A549 secretome identifies putative regulators of epithelial-mesenchymal transition.

Proteomic analysis of TGFβ-induced A549 secretome identifies putative regulators of epithelial-mesenchymal transition.

Journal: Biotechnology and applied biochemistry

Published: September 02, 2020

E3 ligase SCFSKP2 ubiquitinates and degrades tumor suppressor C/EBPα in acute myeloid leukemia.

E3 ligase SCFSKP2 ubiquitinates and degrades tumor suppressor C/EBPα in acute myeloid leukemia.

Journal: Life sciences

Published: April 17, 2020

Chebulinic acid inhibits MDA-MB-231 breast cancer metastasis and promotes cell death through down regulation of SOD1 and induction of autophagy.

Chebulinic acid inhibits MDA-MB-231 breast cancer metastasis and promotes cell death through down regulation of SOD1 and induction of autophagy.

Journal: Cell biology international

Published: April 02, 2020

FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1.

FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1.

Journal: Molecular cancer research : MCR

Published: March 23, 2020

CDK2 destabilizes tumor suppressor C/EBPα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.

CDK2 destabilizes tumor suppressor C/EBPα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.

Journal: Journal of cellular biochemistry

Published: June 11, 2019

Nano-LC based proteomic approach identifies that E6AP interacts with ENO1 and targets it for degradation in breast cancer cells.

Nano-LC based proteomic approach identifies that E6AP interacts with ENO1 and targets it for degradation in breast cancer cells.

Journal: IUBMB life

Published: May 24, 2019

Patterns and determinants of dyslipidaemia in 'Young' versus 'Not so Young' patients of coronary artery disease: a multicentric, randomised observational study in northern India.

Patterns and determinants of dyslipidaemia in 'Young' versus 'Not so Young' patients of coronary artery disease: a multicentric, randomised observational study in northern India.

Journal: Indian heart journal

Published: June 06, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026